S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
Log in

CM Life Sciences Stock Forecast, Price & News

+0.40 (+2.50 %)
(As of 03/5/2021 12:00 AM ET)
Today's Range
Now: $16.41
50-Day Range N/A
52-Week Range
Now: $16.41
Volume3.40 million shs
Average Volume2.12 million shs
Market Capitalization$908.20 million
P/E RatioN/A
Dividend YieldN/A
CM Life Sciences, Inc. intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company was founded in 2020 and is based in New York, New York.

Industry, Sector and Symbol

Industry Shell Companies
Current SymbolNASDAQ:CMLF
Phone212 474 6745
Year FoundedN/A



Sales & Book Value

Annual SalesN/A



Market Cap$908.20 million
Next Earnings DateN/A


Overall MarketRank

0.00 out of 5 stars

Financial Services Sector

624th out of 658 stocks

Shell Companies Industry

226th out of 276 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
+0.40 (+2.50 %)
(As of 03/5/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CMLF News and Ratings via Email

Sign-up to receive the latest news and ratings for CMLF and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

CM Life Sciences (NASDAQ:CMLF) Frequently Asked Questions

What stocks does MarketBeat like better than CM Life Sciences?

Wall Street analysts have given CM Life Sciences a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but CM Life Sciences wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting CM Life Sciences?

CM Life Sciences saw a increase in short interest in February. As of February 12th, there was short interest totaling 435,100 shares, an increase of 60.8% from the January 28th total of 270,600 shares. Based on an average daily volume of 1,210,000 shares, the days-to-cover ratio is presently 0.4 days.
View CM Life Sciences' Short Interest

Who are CM Life Sciences' key executives?

CM Life Sciences' management team includes the following people:
  • Mr. Eli Decatur Casdin, CEO & Director
  • Mr. Brian Emes, CFO & Sec. (Age 38)
  • Dr. Shaun Kevin Rodriguez, Chief Strategy Officer (Age 43)

Who are some of CM Life Sciences' key competitors?

What is CM Life Sciences' stock symbol?

CM Life Sciences trades on the NASDAQ under the ticker symbol "CMLF."

Who are CM Life Sciences' major shareholders?

CM Life Sciences' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Virtu Financial LLC (0.02%).

Which major investors are buying CM Life Sciences stock?

CMLF stock was purchased by a variety of institutional investors in the last quarter, including Virtu Financial LLC.

How do I buy shares of CM Life Sciences?

Shares of CMLF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is CM Life Sciences' stock price today?

One share of CMLF stock can currently be purchased for approximately $16.41.

How much money does CM Life Sciences make?

CM Life Sciences has a market capitalization of $908.20 million.

What is CM Life Sciences' official website?

The official website for CM Life Sciences is cmlifesciencesspac.com.

How can I contact CM Life Sciences?

The company can be reached via phone at 212 474 6745.

This page was last updated on 3/6/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.